Related Experiment Videos
GABA-benzodiazepine interactions: physiological, pharmacological and developmental aspects
Federation Proceedings
|October 1, 1980
Summary
Benzodiazepines enhance gamma-aminobutyric acid (GABA) inhibition in the brain. This interaction is crucial from development through maturity, suggesting a shared complex for their action.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Benzodiazepines exert pharmacological effects through interactions with gamma-aminobutyric acid (GABA) systems in the brain.
- Electrophysiological studies show benzodiazepines potentiate GABAergic inhibition in dorsal raphe neurons.
Purpose of the Study:
- To investigate the functional interaction between benzodiazepines and GABA during development and maturity.
- To elucidate the molecular mechanisms underlying benzodiazepine-GABA interactions.
Main Methods:
- Direct binding studies using [3H]diazepam and [3H]GABA in cerebral cortical tissue.
- Electrophysiological recordings from dorsal raphe neurons.
- Analysis of ontogenic development of binding sites.
Main Results:
- Benzodiazepine binding to its site is enhanced by GABA and GABA agonists.
- GABA's enhancement of benzodiazepine binding is present throughout development and inversely related to age.
- [3H]diazepam binding development parallels sodium-independent [3H]GABA binding.
Conclusions:
- A functionally significant interaction exists between benzodiazepines and GABA throughout development and at maturity.
- A model involving a benzodiazepine/GABA/Cl- ionophore complex is proposed to explain these interactions.